Skip to content
healthcare.dev

Sildenafil

NDC 0591-4050, Sildenafil, powder, for suspension, from Actavis Pharma, Inc..

Product NDC
0591-4050
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211534
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-4050 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SILDENAFIL CITRATE10 mg/mL

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
0591-4050-94005914050941 BOTTLE in 1 CARTON (0591-4050-94) / 112 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0e6428c0-e0e9-4fc0-8615-6a9678d2286c
  • NADAC price for package 00591405094

    GET /v1/drugs/nadac/00591405094

Use it

Look up 0591-4050 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-4050 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-4050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.